GONADAL DYSGENESIS (TURNERβS SYNDROME), BY SUBCUTANEOUS INJECTION, 45 - 50 MICROGRAMS/KG DAILY OR 1.4 MG/M2 DAILY
DEFICIENCY OF GROWTH HORMONE IN CHILDREN, BY SUBCUTANEOUS OR INTRAMUSCULAR INJECTION, 23 - 39 MICROGRAMS/KG DAILY OR 0.7 - 1 MG/M2 DAILY
GROWTH DISTURBANCE IN SHORT CHILDREN BORN SMALL FOR GESTATIONAL AGE WHOSE GROWTH HAS NOT CAUGHT UP BY 4 YEARS OR LATER, BY SUBCUTANEOUS INJECTION, 35 MICROGRAMS/KG DAILY OR 1 MG/M2 DAILY
PRADER-WILLI SYNDROME, BY SUBCUTANEOUS INJECTION IN CHILDREN WITH GROWTH VELOCITY GREATER THAN 1 CM/YEAR, IN COMBINATION WITH ENERGY-RESTRICTED DIET, 35 MICROGRAMS/KG DAILY OR 1 MG/M2 DAILY; MAX. 2.7 MG DAILY
CHRONIC RENAL INSUFFICIENCY IN CHILDREN (RENAL FUNCTION DECREASED TO LESS THAN 50%), BY SUBCUTANEOUS INJECTION, 45 - 50 MICROGRAMS/KG DAILY OR 1.4 MG/M2 DAILY (HIGHER DOSES MAY BE NEEDED) ADJUSTED IF NECESSARY AFTER 6 MONTHS
ADULT GROWTH HORMONE DEFICIENCY, BY SUBCUTANEOUS INJECTION, INITIALLY 150 - 300 MICROGRAMS DAILY, GRADUALLY INCREASED IF REQUIRED TO MAX. 1 MG DAILY; USE MINIMUM EFFECTIVE DOSE (REQUIREMENTS MAY DECREASE WITH AGE)
NOTE DOSE FORMERLY EXPRESSED IN UNITS; SOMATROPIN 1 MG = 3 UNITS